Fig. 2From: Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccinesEndocytosis of LNP-mRNAs / EV-proteins for immune interaction. AÂ Most of the internalized LNP-mRNAs will be shuttled to the lysosome and a small fraction will escape from the endosomes to release mRNA for protein translation. Some of the newly translated proteins could undergo degradation by the proteasome for MHC class I antigen presentation to CD8+ T cells Others could be displayed on the cell surface or secreted into the extracellular space. BÂ The membrane-bound or secreted proteins when endocytosed by APCs will be processed in the lysosomes for MHC class II antigen presentation to CD4+ T cells. CÂ Most of the internalized EV-proteins will be shuttled to the lysosome and a small fraction will escape from the endosomes to release protein for degradation by the proteasome and MHC class I antigen presentation to CD8+ T cells. DÂ When EV-proteins are endocytosed by APCs, the poor endosomal escape enhances lysosomal processing of the proteins and facilitates MHC class II antigen presentation to CD4+ T cells. ERÂ endoplasmic reticulum, TCRÂ T cell receptor, APCÂ antigen-presenting cellBack to article page